Significant Ownership of Laurence W. Lytton

Signature - Title
/s/ Laurence W. Lytton - Reporting Person
Location
NY, NY
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by Laurence W. Lytton.

Notify me when Laurence W. Lytton files a new Schedule 13D/G report.

⭐ Subscribe ⭐

Significant Ownership of Laurence W. Lytton

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
LIQT LIQTECH INTERNATIONAL INC Common Stock 10% $2,783,876 1,058,508 Lytton-Kambara Foundation 30 Sep 2025
AYTU AYTU BIOPHARMA, INC Common Stock 10% $1,857,953 +$991,658 1,086,522 +114% LYTTON LAURENCE W 30 Sep 2025
GUER GUERRILLA RF, INC. Common Stock 10% $1,142,588 1,088,179 Lytton, Laurence W. 28 Mar 2024
APRE Aprea Therapeutics, Inc. Common Stock 9.9% $913,662 681,837 LYTTON LAURENCE W 13 Nov 2025
CLRB Cellectar Biosciences, Inc. Common Stock 8.8% $1,067,977 3,955,470 LYTTON LAURENCE W 31 Dec 2024
TLPH TALPHERA, INC. Common Stock 8% $1,890,909 3,636,364 LYTTON LAURENCE W 10 Sep 2025
SONM SONIM TECHNOLOGIES INC Common Stock 7.8% $51,962 -$589,891 79,941 -92% LYTTON LAURENCE W 30 Sep 2025
CGEH Capstone Green Energy Holdings, Inc. Common Stock 7.7% $8,941,339 1,771,404 LYTTON LAURENCE W 25 Nov 2025
TELA TELA Bio, Inc. Common Stock 7.2% $4,269,304 -$832,740 2,865,305 -16% Lytton, Laurence W. 30 Sep 2025
XTNT Xtant Medical Holdings, Inc. Common Stock 6.8% $4,447,818 9,463,442 Laurence W. Lytton 15 Apr 2025
MDXH MDxHealth SA Ordinary Shares 6.4% $14,709,280 -$3,655,360 3,163,286 -20% LYTTON LAURENCE W 30 Sep 2025
ELWT Elauwit Connection, Inc. Common Stock 5.9% $2,779,150 390,879 LYTTON LAURENCE W 15 Dec 2025
CREX CREATIVE REALITIES, INC. Common Stock 5.1% $1,223,591 +$213,230 534,436 +21% LYTTON LAURENCE W 28 Oct 2025
DUOT DUOS TECHNOLOGIES GROUP, INC. Common Stock 5% $2,408,291 427,002 LYTTON LAURENCE W 31 Jan 2024
SMTK SmartKem, Inc. Common Stock 4.9% $645,891 -$320,775 222,721 -33% Lytton, Laurence W. 31 Mar 2025
ELVA Electrovaya Inc. Common Shares 4.7% $11,469,489 -$3,288,097 1,898,922 -22% Lytton, Laurence W. 30 Jun 2025
EVOK Evoke Pharma Inc Common Stock, par value $0.0001 3.9% $138,479 61,274 Lytton, Laurence W. 31 Mar 2025
BFRI Biofrontera Inc. Common Stock, par value $0.001 3.5% $245,360 306,700 LYTTON LAURENCE W 31 Mar 2025
NMTC NEUROONE MEDICAL TECHNOLOGIES Corp Common Stock, par value $0.001 2.6% $608,785 1,295,288 LYTTON LAURENCE W 31 Mar 2025
CLRB Cellectar Biosciences, Inc. Common Stock 1.6% $247,705 51,391 LYTTON LAURENCE W 30 Jun 2025
EMKR EMCORE CORP Common Stock 1.4% $394,948 126,948 LYTTON LAURENCE W 31 Dec 2024
XGN EXAGEN INC. Common Stock, par value $0.001 per share 1% $2,135,874 216,840 LYTTON LAURENCE W 30 Jun 2025
SCPH scPharmaceuticals Inc. Common Stock 0% $0 0 LYTTON LAURENCE W 30 Sep 2025

Schedules 13D/G Reported by Laurence W. Lytton:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Filing Date
* An asterisk sign (*) next to the price indicates that the price is likely invalid.